OIEPX | VIVIX | OIEPX / VIVIX | |
Total Expense Ratio | 0.95 | 0.04 | 2,375% |
Annual Report Gross Expense Ratio | 0.95 | 0.04 | 2,375% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | 10.106 | 7.866 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 43.9B | 203B | 22% |
Annual Yield % from dividends | 1.36 | 2.11 | 64% |
Returns for 1 year | 4.53 | 7.74 | 59% |
Returns for 3 years | 23.75 | 36.61 | 65% |
Returns for 5 years | 55.12 | 70.16 | 79% |
Returns for 10 years | N/A | 131.61 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.99 | 0.91 | +2.44% |
Global X Genomics & Biotechnology ETF | |||
SEEM | 28.75 | 0.25 | +0.89% |
SEI Select Emerging Markets Equity ETF | |||
VEU | 69.74 | 0.44 | +0.63% |
Vanguard FTSE All-Wld ex-US ETF | |||
WIA | 8.40 | 0.02 | +0.30% |
Western Asset Inflation-Linked Income Fund | |||
FAPR | 43.14 | N/A | +0.01% |
FT Vest US Equity Buffer ETF Apr |